A widely available antidepressant promises as a treatment for Covid-19, according to a new study. Covid-19 patients receiving fluvoxamine were significantly less likely to require hospitalization than those who did not, in the largest clinical trial evaluating the effect of antidepressants on Covid-19 to date. .
Economic incentives, public health announcements, and other tactics used by state and local governments and employers to encourage people to get the Covid-19 vaccine did not have a noticeable effect on vaccination rates among those already hesitant to get the shot, new shows research. Moreover, the strategies sometimes had the opposite effect of their intended … Read more